A Phase 1b Study of JNJ-90014496 in Adult Participants with Relapsed or Refractory B-cellNon-Hodgkin Lymphoma
Phase 1
Recruiting
- Conditions
- on-Hodgkin Lymphoid MalignanciesTherapeutic area: Diseases [C] - Neoplasms [C04]
- Registration Number
- CTIS2023-506267-33-00
- Lead Sponsor
- Janssen - Cilag International
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 54
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: ;Secondary Objective: ;Primary end point(s):
- Secondary Outcome Measures
Name Time Method